In this conversation with faculty colleague Dr. Cheryl Fisher, Alliant MS in Clinical Psychopharmacology program director Dr. George Kapalka discusses his extensive experience and insights into RxP, particularly focusing on pediatric populations. He highlights the evolution of training for psychologists in this field, the challenges faced in prescribing medications to children, and the impact of political changes on pharmaceutical research. The discussion also covers the collaboration between counselors and prescribers, addressing client resistance to medication, and the influence of telehealth on psychopharmacology. Finally, Dr. Kapalka provides valuable advice for clinical counselors and shares his thoughts on future trends in the field based on questions from Alliant students.

This episode of Psychopharmacology Today explores the significance of interprofessional collaboration in healthcare, particularly between psychology and primary care. Dr. Alice Davis shares her journey from nursing to psychology, emphasizing the importance of teamwork in managing patient care. Through personal anecdotes and case studies, she illustrates the benefits and challenges of collaborative practice, advocating for a more integrated approach to healthcare that includes diverse professionals working together for better patient outcomes.

This episode of Psychopharmacology Today explores the complexities surrounding medical cannabis, focusing on the scientific, legal, and practical aspects that clinicians need to understand. Dr. Randall Tackett discusses the differences between medical and recreational cannabis, the role of cannabinoids like THC and CBD, and the importance of the endocannabinoid system. He highlights the medical applications of cannabis, the risks associated with its use, and the need for better education among healthcare professionals regarding cannabis. Dr. Tackett also addresses the legal landscape of medical cannabis and the challenges faced by patients and providers.